Literature DB >> 25050155

Pim kinase inhibitors for the treatment of cancer and possibly more.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2014        PMID： 25050155      PMCID： PMC4094249          DOI： 10.1021/ml5001678

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  The PIM kinases in hematological cancers.

Authors:  Yesid Alvarado; Francis J Giles; Ronan T Swords
Journal:  Expert Rev Hematol       Date:  2012-02       Impact factor: 2.929

Review 2.  The Pim kinases: new targets for drug development.

Authors:  Ronan Swords; Kevin Kelly; Jennifer Carew; Stefan Nawrocki; Devalingam Mahalingam; John Sarantopoulos; David Bearss; Francis Giles
Journal:  Curr Drug Targets       Date:  2011-12       Impact factor: 3.465

Review 3.  Pim kinases in cancer: diagnostic, prognostic and treatment opportunities.

Authors:  Carmen Blanco-Aparicio; Amancio Carnero
Journal:  Biochem Pharmacol       Date:  2012-10-05       Impact factor: 5.858
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.